Answers are grounded in this paper and cite their sources.
Cerebral venous sinus thrombosis (CVST) is an uncommon but potentially serious complication of glioblastoma that may be overlooked because neurological deterioration is frequently attributed to tumor progression, edema, seizures, infection, or treatment effects. We report a 58-year-old man with World Health Organization grade 4, IDH-wild-type glioblastoma who developed progressive encephalopathy and an increasing seizure burden approximately five months after diagnosis while receiving maintenance temozolomide. Initial evaluation identified aspiration pneumonia, subtherapeutic valproic acid levels, vasogenic edema, and communicating hydrocephalus, and electroencephalography showed generalized slowing with repeated epileptiform discharges. Treatment with antibiotics, corticosteroids, and antiseizure optimization led to partial improvement, with the Glasgow Coma Scale increasing from 9/15 to 11/15. Contrast-enhanced magnetic resonance imaging, performed to assess suspected tumor progression, showed stable residual tumor and an unexpected filling defect in the left transverse and sigmoid sinuses extending into the proximal internal jugular vein. Therapeutic low-molecular-weight heparin was initiated, and the patient remained neurologically stable without clinical evidence of hemorrhage until discharge. This case highlights that neurological decline in glioblastoma is often multifactorial and should not be automatically attributed to tumor progression. Careful review of contrast-enhanced imaging and dedicated venous imaging can identify a treatable thrombosis that may otherwise be missed.
No takes yet. Share an insight, caveat, or question.
Deek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: